⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 18, 2026

Olanzapin 1A Pharma 2,5 mg - Filmtabletten 2,5 mg (Filmtablette)

📷 Wikipedia: Olanzapine · Source
Olanzapin 1A Pharma 2,5 mg - Filmtabletten 2,5 mg (Filmtablette)
📷 Wikipedia: Olanzapine · Source
Olanzapine 1A Pharma 2.5 mg film-coated tablets are unavailable due to manufacturing shortages. Only the 7-tablet pack remains available.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 40 days ago.
📈 Timeline
15 days in total
June 19, 2026 July 4, 2026

What is this? Olanzapin is a medicine used to treat mental health problems. It comes as small tablets you swallow.

What's happening? Some packs of this medicine are hard to find right now. Only the smaller packs are still available.

Does this affect me? If you take this medicine, check if your usual pack is missing.

What should I do? Ask your pharmacist or doctor for help finding another pack or brand.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
OLANZAPIN
Agency-published detail

ATC: N05AH03 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-06-18] · 7 Stück Schachtel, Blisterpackung [verfügbar]

First published
June 18, 2026
Last refreshed by us
3 weeks ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT 1 week ago

ZYPADHERA 405 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension 405 mg (Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension)

ZYPADHERA 405 mg powder and solvent for preparing a depot injection suspension 405 mg is temporarily unavailable due to a delay in finished product release. No further details are provided.
Low AT 1 week ago

Olanzapin Sandoz 10 mg - Filmtabletten 10 mg (Filmtablette)

Olanzapine Sandoz 10 mg film-coated tablets. The 28-tablet pack is unavailable; only the 7-tablet pack remains.
Low AT 2 weeks ago

Olanzapin 1A Pharma 10 mg - Filmtabletten 10 mg (Filmtablette)

Olanzapine 1A Pharma 10 mg film-coated tablets.
Low AT 2 weeks ago

Olanzapin 1A Pharma 5 mg - Filmtabletten 5 mg (Filmtablette)

Olanzapine 1A Pharma 5 mg film-coated tablets.
Low AT 2 weeks ago

Olanzapin-ratiopharm 15 mg Tabletten 15 mg (Tablette)

Olanzapine-ratiopharm 15 mg tablets are delayed. The 28-tablet pack is unavailable since 7 July 2026; the 7-tablet pack remains available.
Low AT 2 weeks ago

ZYPREXA 10 mg Pulver zur Herstellung einer Injektionslösung 10 mg (Pulver zur Herstellung einer Injektionslösung)

Parallel export ban active. Supply delayed.
Medium AT resolved 1 month ago

Olanzapin Sandoz 2,5 mg - Filmtabletten 2,5 mg (Filmtablette)

Olanzapine Sandoz 2.5 mg film-coated tablets are unavailable due to manufacturing shortages. Only the 7-tablet pack remains available.
Medium AT resolved 2 months ago

ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension 210 mg (Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension)

ZYPADHERA 210 mg powder and solvent for preparing a depot injection suspension 210 mg is currently unavailable. No further details are provided.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Olanzapin 1A Pharma 2,5 mg - Filmtabletten 2,5 mg (Filmtablette). Olanzapine 1A Pharma 2.5 mg film-coated tablets are unavailable due to manufacturing shortages. Only the 7-tablet pack remains available.
▸ When was this alert issued?
This alert was issued on June 18, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.